Beyond the complications: medium-term anatomical, sexual and functional outcomes following removal of trocar-guided transvaginal mesh. A retrospective cohort study
International Urogynecology Journal, 04/30/2012
There were no symptoms relating to prolapse in any of the women at 6 weeks, 6, 12 or 24 months. Authors report satisfactory outcomes following removal of a complicated TVM kit.
This was a retrospective analysis of a clinical database of women who had developed a complication following a TVM procedure.
This included dyspareunia, mesh erosion, urinary symptoms, mesh contraction and prolapse recurrence.
Pre– and post–operatively, we assessed the women for prolapse, stress incontinence, urgency, defecatory difficulty, digitation, pain, dyspareunia and apareunia.
They also recorded the Pelvic Organ Prolapse Quantification (POP–Q) score.
The TVM was removed and a Biodesign graft was used in the majority of cases to prevent further prolapse.
Follow–up was at 6 weeks, 6 months, 1 and 2 years.
In the cohort of 21 women, 18 required surgery for pain and/or dyspareunia; 20 women had reached the 6–week follow–up at the time of analysis.
At 6 weeks, two women still had pain and required a second intervention.
Fifteen women had reached a 6–month follow–up and only one woman had persistent pain requiring repeat surgery.
Of the 15 women, 7 were sexually active and in 6 cases the dyspareunia had resolved completely with 1 woman retaining an element of pain at intercourse.
Six women had been seen at 12 months and all four of the sexually active women had no dyspareunia.
There were no symptoms relating to prolapse in any of the women at 6 weeks, 6, 12 or 24 months.